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Introduction	  	  
On June 5, 2017, the long awaited date for the Nobel Symposium in Microfluidics at Sånga 
Säby conference resort in the countryside west of Stockholm had arrived. Full of 
expectations, the hosts for the symposium, Johan Elf and Thomas Laurell, welcomed 
attendees to an exciting four days Odyssee through the discoveries and developments 
within the microfluidics and lab-on-a-chip field.  
The Nobel Foundation's Symposium programme was initiated in 1965 and since then over 
160 symposia have taken place. With the Nobel symposium nr 162, we had the ambition to 
cover the past, current and future developments of microfluidics; a highly challenging task 
as there are many excellent researchers in this area and only thirty slots in the program. 
We tried to cover the early breakthrough contributions to the field, important developments 
over the years and applications of microfluidics that now propagate in vastly different 
directions both as industrial components or processes and as tools and methods supporting 
fundamental research. 
Attendees of the No 162 Nobel Symposium – Microfluidics lined up in the sun in front of the 
sundeck at Sånga Säby conference resort. 
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The opening lecture of the symposium was given by Professor George Whitesides who set 
the stage and the level for the week to come with statements that challenged the auditorium 
in terms of questioning why we do what we do and how the research performed can benefit 
society both in terms of creating industries, facilitate health care and benefit mankind. 
The symposium program was mixed with some of the early 
pioneers in the field featuring Andreas Manz, Jed Harrison, 
Michael Ramsey and Richard Mathies, who all reflected on 
the early days of microchip based separations and the boom 
and hype created in the era of CE driven genome 
sequencing. A large part of the symposium highlighted the 
different development routes that the microfluidics field 
subsequently followed as material and fabrication 
technologies matured, enabling simple manufacturing of 
microfluidic circuits without the need for clean room 
facilities.  
Important contributions and application developments were highlighted by Takehiko 
Kitamori, James Landers, Klavs Jensen, Albert van den Berg, Luke Lee and not least David 
Weitz, who took us through the decades describing a research branch that went from 
science fiction, through the stages of infinite promise, brisk reality check and finally 
scientific maturity and commercial and industrial implementation. That the field will 
continue to thrive also in the future was made clear by Sindy Tang, Amy Herr, Paul 
Blainey, Tomas Knowles, Andrew DeMello, Hang Lu, Yoon-Kyoung Cho and Roland 
Zengerle who convinced the audience that the only real limits are those of your imagination 
and that indeed microfluidics can solve real problems.  
Mehmet Toner demonstrated that microfluidics has a place also in the macro-world, 
showing the ability to scale microfluidics to clinical applications still benefitting from the 
high performance of microscale. David Bebee followed the “make it simple” mantra and 
demonstrated important applications of autonomous microfluidic systems and simple 
solutions to clinical applications. Shoji Takeuchi outlined new strategies to address the 
unmet needs in regenerative medicine and Jay Han’s pulled the attention to microfluidic 
opportunities in chemical engineering for molecular and ionic separations. 
That the microfluidic techniques are increasingly used as workhorses in biological research 
was obvious from the presentations by Stephen Quake, Jianhua Qin, Sabeth Verpoorte, 
Petra Dittrich and Joel Voldman, while Henrik Bruus presented theoretical aspects of 
microscale acoustofluidics and novel acoustophysics only revealed in confined space.  
Having had the opportunity to gather this extraordinary line up of internationally top 
researchers in the field of microfluidics was a once in a life time event and indeed the 
euphoria was mutually contagious between the participants, sparking lively discussions late 
at night and throughout the week, with full attendance until the very end. No one wanted to 
miss anything! In summary, we as symposium chairs (Johan and Thomas) were privileged 
to get the opportunity to organize Nobel Symposium No. 162, devoted to the topic of 
Microfluidics. 
 
George Whitesides, 
Stockholm, Sweden, 2017 
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To give the entire research community an opportunity to sample the science presented at 
the symposium we have compiled a symposium volume that reflects the major messages 
conveyed by our invited speakers. We are deeply grateful to the effort that our participants 
put into writing their lecture notes/abstracts. Most notably we all acknowledge the efforts 
that Irmeli Barkefors put into all the practical arrangements and herding of the participants 
throughout the week.  
Thomas Laurell & Johan Elf 
 
The	  Nobel	  Symposia	  
The Nobel Foundation's Symposium programme was initiated in 1965. Since then about 
160 symposia have taken place. The Nobel Symposia programme has obtained a good 
reputation and now plays a significant role in the international exchange of knowledge and 
experience. 
The financial base for the Nobel Symposia programme consists of funds received from 
Riksbankens Jubileumsfond and the Knut and Alice Wallenberg Foundation. 
 
The	  Organizers	  
Thomas Laurell is Professor in Medical and Chemical Microsensors 
since 2000 with a focus on Lab-On-A-Chip technologies in 
biomedicine at the Department of Biomedical Engineering, Div. 
Nanobiotechnology and Lab-on-a-chip. He received his PhD in 
electrical engineering in 1995 at Lund University and obtained a 
position as associate professor in 1998 at Lund University performing 
research on lab-on-a-chip technology interfaced to mass spectrometry 
proteomics and disease biomarker research as well acoustic 
manipulation of cells and particles in microfluidics systems. In 2005 
Laurell co-founded the Chemical and Biological Microsystems Society, CBMS, the ruling 
body of the MicroTAS conference series and served as the President of CBMS, 2009-2017. 
He has also cofounded the Centre of Excellence in Biological and Medical Mass 
Spectrometry, a national infrastructure node at Lund University.  
Johan Elf is Professor in Biological Physics at Uppsala University. 
Together with his interdisciplinary research team, Johan is pioneering 
single-molecule tracking methods by means of fluorescence 
microscopy in living cells. After obtaining his PhD on a theoretical 
subject in 2004, Johan Elf spent a more experimentally oriented 
postdoc period in the lab of Sunny Xie at Harvard University, 
developing the first methods for studying transcription factor binding 
at the level of single molecules in living cells. In the years following 
his return to Uppsala in 2007, Johan has focused his efforts on the 
study of gene regulation in bacteria, successfully combining theoretical and computational 
biology with experimental work and methods development to tackle challenging biological 
problems related to the central dogma of molecular biology.   
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Practical	  (Simple)	  Microfluidics	  
David J. Beebe - University of Wisconsin-Madison 
 
Biography	  
David J. Beebe is the Claude Bernard Professor of Biomedical 
Engineering, Co-Leader of the Tumor Microenvironment 
Program in the UW Carbone Cancer Center, and a John D. 
MacArthur Professor at the University of Wisconsin-Madison. 
David’s current research interests center on the understanding 
and application of micro scale physical phenomena to 
understand cancer biology (e.g. stromal-epithelial and cell-
matrix interactions), to improve cancer diagnosis and 
monitoring and to advance global disease diagnostics. 
Context	  
Back in the early 1990’s I recall giving (and listening to) presentations having the 
obligatory list (a fairly long one) of all the potential advantages of this exciting new field of 
microfluidics. I won’t dwell on the details, but suffice it to say that many of those supposed 
advantages either didn’t turn out to be true or didn’t turn out to be as sizable of an 
advantage as originally imagined. Despite the oversized expectations and never ending 
hope of a “killer app”, significant progress has been made and microfluidics is having 
impact in a number of areas (albeit often hidden from view). Here, I’ll focus on consistent 
themes that have been central to the path we have taken as we strive to do something useful 
with microfluidics. Our focus has always been less on the engineering and more on the 
physics. That is to say we strive to find simple ways to leverage the dominance of certain 
phenomena at the micro scale to create simple, hopefully practical and sometimes fun 
functionality. 
Influences	  
While we are all influenced by all that came before, I was probably most influenced by the 
work of two physicists - Edward Purcell and Robert Austin. Purcell illustrated the 
importance of understanding the basic physical phenomena at play and the elegance with 
which organisms have adapted to and leveraged such phenomena (Purcell, 1976). Austin 
expanded this notion by illustrating how to exploit this understanding of the physics in 
clever and fun ways to create intriguing micro scale devices and systems capable of new 
things. By way of example they also showed that one doesn’t need to be bound by 
disciplinary borders.  
Simple	  equations	  
While I like to say I’ve focused on the physics, I’m not a physicist. So our way of 
“focusing on the physics” is by way of basic equations of transport (Fick’s Laws) and 
interfaces (Laplace’s Law) as well as dimensionless numbers prevalent in engineering 
textbooks (I believe there are over 50 such numbers). These simple equations allow one to 
think intuitively (for better or worse) without getting dragged into the details of the physics 
(apologies to the physicists - for a detailed examination of the physics of these numbers in 
the context of microfluidics see review by Squires & Quake, 2005). While Reynolds 
   
 
number (inertial, viscous) dominated in the early days of the field, I’m particularly fond of 
Peclet (diffusion, convection), Capillary (viscous, capillary)(Atencia, 2005), and, more 
recently, Bond (or Eötvös) (surface tension, body) numbers (Berry, 2011). 
Simple	  Examples	  
I provide a few representative examples of our work here. Additional examples in 
presentation.  
Autonomous operation (Simple & Fun) 
One of our first forays into leveraging physics in microfludics was to take advantage of 
short distances to create autonomously operating systems. While stimuli responsive 
materials (specifically hydrogels) were well known and well known to operate very slowly, 
we simply shrunk them down and used them inside microchannels to create autonomously 
operating components (e.g. valves, Beebe, Nature, 2000; Yu, APL, 2001) and systems (e.g. 
closed loop feedback, Eddington, LOC, 2001).  
Open microfluidics (Simple, Practical & Fun) 
About the same time, we began to think about surface tension (i.e. Young-LaPlace equation 
& Bond number) and create “open” micro scale devices - broadly defined as having at least 
one “side” open to the environment (or lacking a solid wall). Our initial work focused on 
surface patterning to control fluid with only a top and a bottom surface in contact with the 
fluid and the sides having contact only with air forming “virtual” walls (Zhao, Science, 
2001). We also developed passive pumping schemes based on the principles described by 
Young-LaPlace equation (Walker, LOC, 2002). More recently we have expanded these 
concepts into “suspended microfluidics (Casavant, PNAS, 2013). 
Where	  to	  next	  
Applications to biology and medicine (Simple & Practical) 
Since retraining in cancer biology (2004-2009) we have turned much of our attention to the 
application of microfluidics to both study basic biology as well as improve clinical decision 
making. We have learned that very simple embodiments of microfluidics (e.g. 
compartmentalization) can prove quite useful in exploring important questions in cancer 
biology (e.g. fibroblast-epithelia interactions, Sung, Integrative Biology, 2011), examining 
multi-kingdom interactions (e.g. mammalian-fungi signaling, Berthier, Plos Pathogens, 
2013), and predicting patient response (e.g. stromal-epithelia interactions, Pak, Integrative 
Biology, 2015). Leveraging surface tension can allow discovery of new molecular 
interactions (e.g. protein-protein binding, Moussavi-Harami, J Proteome Research, 2013), 
low cost diagnostics (e.g. HIV viral load, Berry, PlosOne, 2015) and multi-omic analysis 
from a single sample (e.g. Sperger, Clinical Cancer Research, 2016). 
Acknowledgements	  
From 1996-1999 I was at the University of Illinois Urbana Champaign (UIUC). At UIUC, 
Juan Santiago, Jeff Moore, Matt Wheeler, Mark Shannon, Richard Magin and Ron Adrian 
all influenced my thinking in important ways. At the University of Wisconsin I’m indebted 
to Anna Huttenlocher, Caroline Alexander and Josh Lang for helping me see beyond the 
physical science of things. And thanks to the many current biological and medical 
collaborators that are too numerous to list. And most importantly all the students, post-docs 
and scientists who have passed through the lab over the years - they are the heart and soul 
of the work.  
   
 
‘Applied	  Nanofluidics’	  for	  Biomedical	  
and	  Chemical	  Engineering	  
Jongyoon Han - Massachusetts Institute of 
Technology 
 
Biography	  
Prof. Jongyoon Han is currently a Professor of Electrical 
Engineering as well as a Professor of Biological Engineering, 
at the Massachusetts Institute of Technology. Dr. Han and his 
group pioneered the field of nanofluidic systems, such as 
entropic trapping DNA separation[1], efficient biomolecule 
concentration systems[2, 3], Anisotropic Nanofilter Array 
(ANA) structure[4] for continuous size-separation of proteins. Due to his significant 
contribution to nanofluidic device engineering, he received 2009 Analytical Chemistry 
Young Innovator Award from the American Chemical Society. He is also a recipient of 
NSF CAREER Award (2004), and Van Tassel Career Development Chair in 
Biomedical Engineering (2004). Originally focused at biomolecule separation and 
sample processing, his research has recently been making significant contributions in 
different application areas such as water purification[5], advanced neural 
prosthetics[6], and rare blood cell sorting[7], and mesenchymal stem cells (MSCs) 
engineering[8]. In addition, he is quite interested in leading international research and 
educational collaborations. He is currently participating in Singapore-MIT Alliance for 
Research and Technology Centre, remotely managing a thriving research group in 
Singapore. He is also a lead-PI for Kuwait-MIT Signature Project on Brine 
Desalination. 
Abstract	  
Nanofluidic systems, with critical dimension of 10~100nm, are ideal model system for 
various types of nanoporous membranes. Artificially fabricated nanofluidic channels and 
nanopores have been successfully used for studying fundamental molecular / fluidic 
transport behaviors in nanoscale, yet there is much potential to take advantage of 
nanofluidic systems for real-world engineering applications. This seminar will showcase 
several recent examples of such applications my group was working on.   
Nanofluidic molecular separation and concentration 
Previously, we have demonstrated slanted nanofilter arrays and its implementation for 
continuous size-base protein concentration and separation. Using the nanofilter arrays, we 
have developed a system allowing to perform both purity and quality test for protein drugs, 
continuously. Not only could we perform multiple orthogonal analyses in a single device 
platform, but also the separation resolution and detection sensitivity match or exceed 
current tools used in the industry.  
Nanofluidics as a model ion selective membrane 
Ion concentration polarization is an ion transport process that occurs in the vicinity of ion 
selective membranes, which can be created and modeled by micro-nanofluidic systems. We 
   
 
have utilized this fundamental phenomenon for various applications, including biomolecule 
preconcentration, water purification / desalination, and even ion-specific nerve modulation. 
While the study of this multi-physics phenomenon has been challenging, experiments in 
nanofluidic systems allowed one to build a predictive, first-principle-based numerical 
models, with significant implications on membrane science and engineering.  
References	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modulated inertial microfluidics for high throughput rare blood cell separation. Lab Chip, 
2011. 11(11): p. 1870 - 1878. 
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cell cycle synchronization using inertial forces in spiral microchannels. Lab Chip, 2011. 
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Electrophoretic	  cytometry	  for	  high-­‐
selectivity	  proteomics	  
Amy E. Herr - University of California, Berkeley  
 
Biography	  
Amy E. Herr is the Lester John & Lynne Dewar Lloyd 
Distinguished Professor of Bioengineering at the University 
of California, Berkeley and a Chan Zuckerberg (CZ) Biohub 
Investigator. Prior to joining UC Berkeley, she was a staff 
member at Sandia National Laboratories (Livermore, CA), 
earned Ph.D. and M.S. degrees in Mechanical Engineering 
from Stanford University, and completed her B.S. in 
Engineering and Applied Science with honors from the 
California Institute of Technology. Her research has been recognized by the NIH New 
Innovator Award, NSF CAREER Award, Alfred P. Sloan Fellowship (Chemistry), and 
DARPA Young Faculty Award. Professor Herr has chaired the Gordon Research 
Conference (GRC) on the Physics & Chemistry of Microfluidics. She is an elected 
Fellow of the American Institute of Medical and Biological Engineering (AIMBE), an 
entrepreneur, and was recently elected to the US National Academy of Inventors.  Her 
research program lies at the intersection of engineering design, analytical chemistry, 
and targeted proteomics – with a recent focus on cytometry spanning fundamental 
biological to clinical questions 
Abstract	  
From fundamental biosciences to applied biomedicine, high dimensionality data is 
increasingly important. In cytometry tools, microfluidic design has played a key role in 
advancing the throughput, multiplexing and quantitation needed to generate rich data sets. 
Genomics and transcriptomics are leading examples. Yet, measurement of proteins lags. 
While proteins and their dynamic forms are the downstream effectors of function, the 
immunoassay remains the de facto standard (flow cytometry, mass cytometry, 
immunofluorescence) for direct measurement of endogenous, unmodified proteins. We 
posit that to realize the full potential of high-dimensionality cytometry, new approaches to 
targeted protein measurement are needed. 
To address this gap, we have recently introduced a new class of ‘electrophoretic cytometry’ 
tools that increase target selectivity beyond simple immunoassays. Enhanced selectivity is 
essential for targets that lack high quality immunoreagents – as is the case for the vast 
majority of protein forms (proteoforms).  In fundamental engineering and design, I will 
discuss how the physics and chemistry accessible in microsystems allows both the “scale-
down” of electrophoresis to single cells and the “scale-up” to concurrent analyses of large 
numbers of cells. Particular emphasis will be placed on precision control of fluids and 
materials transport in passive systems, with no pumps or valves. Precise reagent control 
allows for integration of cytometry with sophisticated sample preparation – the unsung 
hero of measurement science.  
   
 
Currently, our cytometry research extends two canonical targeted proteomic assays – 
isoelectric focusing and western blotting – to single-cell resolution. Single-cell isoelectric 
focusing (scIEF) is well-suited to profile protein post-translational modifications (PTMs) 
that drive intracellular signaling. Measurement of cell-to-cell variation in PTM-mediated 
signaling is challenging for two reasons. Namely, Immunoreagents lack the selectivity to 
distinguish the literally thousands of unique and combinatorial chemical modifications that 
are possible among proteoforms. This challenge plagues immunoassays. Compounding this 
is the fact that PTMs may change the molecular mass of a protein by a negligible mass 
difference, thus rendering protein sizing alone ineffective in resolving the resulting myriad, 
subtle proteoforms. To overcome these PTM-related challenges in cytometry, we describe 
isoelectric focusing followed by an immunoassay (i.e., immunoprobed IEF). While IEF is a 
mature separation mechanism, state-of-the-art IEF has not yet measured cell-to-cell 
variability owing to analytical sensitivity limitations [2]. Using precision control of mass 
transport and a novel 3D ‘stackable’ microfluidic device, we bring single-cell resolution to 
IEF.   
Our scIEF devices are multi-layer microfluidic device. A 40-µm thick hydrogel “base” 
layer houses microwells that isolate individual cells. When seated on the base layer, a 500-
µm thick hydrogel “lid” layer, patterned with three distinct chemistries – each containing 
the appropriate buffers and ampholytes – delivers lysis reagents and establishes the pH 
gradient necessary for IEF. After chemical lysis of cells (30 s), an electric field is applied 
and each single-cell lysate focuses (E=200 V/cm; 360 s). We observe that the hydrogel lid 
minimizes diffusive protein losses, yielding successful IEF on proteins from single cells. 
An arrayed format simultaneously assays multiple individual cells in parallel. We observe 
pH gradients that are linear, stable, and capable of resolving proteins differing by <0.1 pH 
units. scIEF is rapid, completing in <10-min. After focusing, benzophenone incorporated in 
the base layer is activated with UV (45-sec), thus covalently immobilizing the IEF-resolved 
proteins in the base gel layer. Finally, in-gel immunoprobing reports protein identity, 
correlated with isoelectric point.  
The scIEF assay has reported down to single charge-unit differences in proteoforms from 
single cells engineered to express GFP. We see highly selective measurements of subtle 
chemical protein modifications cells as key to advancing a deeper understanding of the 
complex signaling networks that underlie stem cell differentiation and cancer. Our single-
cell western blotting (scWB) assays are designed to resolve proteins based on molecular 
mass differences (electrophoretic mobility differences) by employing molecular sieving of 
cell lysate via polyacrylamide gel electrophoresis (PAGE). Similar in workflow to the 
scIEF assays, the scWB chips are a single-layer device that uses convective flow (pour 
over) to introduce lysis buffer and utilizes that buffer as the PAGE run buffer. We have 
demonstrated analyses of up to 15 proteins in a single cell, with lower detection limits 
estimated at ~27,000 protein copies. Bringing a multi-layer device architecture to the scWB 
has allowed us to adapt the assay to a compartment-specific, single-cell western blotting for 
nucleo-cytoplasmic profiling, which eliminates the need for complex image segmentation 
algorithms.  
Looking forward, we will detail how these and other electrophoretic cytometry assays 
address driving cytology needs. We will consider ways in which high dimensionality data 
that includes targeted proteomic content enriches our understanding of health and disease.  
Here we will specifically consider the role of protein signaling and truncated isoforms in 
development of breast cancer drug resistance and the variable activation of protein 
signaling among even small populations of individual circulating tumor cells.  
   
Innovating	  Microfluidics	  and	  
Pioneering	  Nanofluidics  
Takehiko Kitamori - The University of Tokyo 
 
 
 
Biography	  
Professor Kitamori is a Professor in the Department of 
Applied Chemistry, School of Engineering, The Uni-versity of 
Tokyo. He was Dean of the Graduate School of Engineering 
(2010-2011), Vice President (2012-2013) and Special 
Assistant to the President (2014), and now he has returned to regular professor to 
devote himself to research and education. His extensive professional career includes 
positions at Hitachi and Kanagawa Academy of Science and Technology. He has 
received numerous honors for his innovative re-search, including an Award from the 
Science and Technology Agency, Chemical Society of Japan Award for Creative Work, 
and an Honorary Doctorate from Lund University, etc. 
1.	  Introduction	  
As well known, microfluidics was initiated by on-chip electrophoresis.  Around the same 
time but a few years later, pressure driven microfluidics was opened independently.  Our 
contribution to this field is to initiate the pressure driven microfluidics, and to pioneer 
nanofluidics.  Regarding to microfluidics, we proposed basic concept and methods to 
innovate microfluidics for pressure driven and widely applicable device technology more 
than electrophoresis, and demonstrated some typical applications which have been still 
main current of microfluidics today.   
Another contribution is to pioneer nanofluidics of which channel width is thousand folds 
smaller than microfluidics, while the concepts and methods are the same.  Nanofluidics has 
been initiating ultimate small scale analytical and general chemistry evolving from mole to 
number of molecules.  It surely brings breakthrough to other science and technology also, 
e.g., single cell single molecule analysis, absolute analysis by molecule counting, and 
solution chemistry and fluid mechanics at molecule level, which may largely contribute to 
life science and medicine.   
Our social contributions to the research community are to found international and domestic 
academic societies, to launch new paper journals and international conferences. This 
lecture introduces these contributions and gives a view of prospects.   
 
 
   
2.	  Microfluidics	  platform	  
Our contribution to both micro- and nanofluidics is establishing the basic platforms for 
general use of the pressure driven microfluidics.  Microfluidics is now mainly going into 
applications.  Immunoassay, cell culture, and extraction are the typical cases, and they need 
various kinds of chemical operations like mixing and reaction, extraction, phase separation, 
and so on.  These chemical operations which are called as unit operation use not only 
aqueous solutions but organic solvents and various kinds of fluid control which are never 
achieved by electrophoretic molecule control and electroosmotic fluid control. Our group 
was the earliest one realizing these unit operations and fluid control in microfluidics and 
opening it to the variety of analytical, biological and even synthesis devices in the 1990's, 
and summarized as micro unit operation MUO in the early 2000's as shown in Fig. 1. The 
methods are as followings:   
m-1) pressure and surface driven 
fluid control  
m-2) MUO and their 
combination for complex multi 
step chemical processing 
m-3) thermal lens micro and 
ultrasensitive detection for 
almost all species (non-
fluorescent) 
m-4) chemical functionalization 
of channel surface for above 
MUO and fluid control 
These four concepts and technologies harmonized to establish our methodology of the 
pressure driven microfluidics, and developed many kinds of applications because of its 
flexibility.  
First of all, we developed our original 
detection method Thermal Lens 
Microscopy (TLM) in 1993, which is a 
kind of photothermal laser spectroscopy 
enabling detection of almost all molecules 
having optical absorption at single to 
countable number level in liquid.  Its 
principle is shown and explained in Fig. 
2a and its caption, and TLM is suitable for 
readout of target molecules in 
microchannel for general use.  By the 
way, our first microchannel was fabricated 
on a slide glass to experiment TLM 
detection in liquid, because the space 
under the microscope was very narrow.  
This microchannel was Y-shaped channel 
Table 1. Micro Unit Operations (MUO). 
 
 
Fig. 1. Chronology of micro/nano fluidics and our contribution. 
 
   
as shown in Fig. 3 and became the origin of MUO which are listed and explained in Table 
1.  Therefore, our strategic two methods of MUO and TLM were combined each other from 
1995. This combination worked well to develop many kinds of chemical and biological 
processing, mixing reaction in 1996, cell culture in 1997, extraction in 1998, immunoassay 
in 1999, and summarized as MUO in 2002 as shown in Fig. 1. Figure 4 shows a 
microfluidic chip for analysis of a trace metal pollutant in water as a typical example.  This 
microfluidics included 10 MUOs and used water sample, organic solvent, and several kinds 
of aqueous solution of reagents. This very complicated chemical process could be 
integrated on a pressure driven microfluidic chip, and the analysis time was reduced from 
several hours to a few minutes and LOD was improved 1000 folds by TLM detection 
comparing to the same analysis in ordinary macroscale.  This device proved the excellent 
natures of microfluidics. 
These applications have been main activities of microfluidics since 2000's, where hundreds 
of papers are published every year worldwide as shown in Fig.1, and today, they are 
actively developing to more sophisticated methodology regardless of droplet or continuous 
fluidics, and of glass or plastic substrate.   
 
 
 
Fig. 2. (a) Thermal lens microscope (TLM): Target 
molecules absorb the excitation light and emit heat 
via non-radiation relaxation.  The emitted heat 
changes refractive index of the solvent around the 
focal area and its distribution acts as a concave 
lens which is called as the thermal lens effect.  The 
probe beam detects the lensing effect which is in 
proportion to the number of molecules.  Almost all 
molecules have this effect, and therefore, the TLM 
can detect almost all kind of the target molecules at 
countable number level. (b) Differential interference 
contrast thermal lens microscope (DIC-TLM): 
Nanochannel is smaller than the wavelength, and 
the thermal lensing effect which is a geographic 
optical effect is not valid.  Therefore, the refractive 
index change induced by the target molecules is 
detected by optical interference between the two 
probe beams.  DIC-TLM also can detect almost all 
kinds of the target molecules in nanochannels very 
high sensitively. 
 
 
 
 
 
 
 
 
 
(Top) Fig. 3. Desktop TLM, and our first 
microfluidic chip for developing the TLM. 
(Bottom) Fig. 4. A microfluidic chip for wet-
analysis of metal pollutant in water.  The 
target pollutant metal ion was chelated in 
the water sample, and the metal chelate 
was extracted to the organic solvent.  
Subsequently, the extraction phase of the 
metal chelate was purified by NaOH and 
HCl solutions, and was sensitively 
determined by the TLM. 
 
   
Space doesn't permit me to explain in details of these applications, but some of them 
have been put into practical use.  For example, our microfluidic immunoassay system 
was commercialized as shown in Fig. 5 and could save some patients' lives in our 
University Hospital by utilizing its flexibility, rapidity and high sensitivity.  A desktop 
chemical plant which contains thousands of microchannels for chemical production has 
been also realized by a company with our collaboration.  On demand production by 
flexible operation, space saving by high efficient chemical processing, and other merits 
are expected. 
3.	  Nanofluidics	  platform	  
Another direction of progress in microfluidics 
is nanofluidics which is 1000 folds smaller in 
size than microfluidics and is smaller than 
wavelength of light.  However, the principle 
of our methodology is basically the same as 
microfluidics listed above from m-1) to m-4);  
n-1) pressure and surface driven fluidics,  
n-2) nano scale unit operation,  
n-3) photothermal readout of target molecules,  
n-4) surface chemical functionalization,  
though some modifications are needed for 
adjusting to nanoscale fluidics.  We published 
a paper concerning the nanofluidic device in 
2002 as shown in Fig. 1, and it was the earliest 
reports of nanofluidics using nanofabricated channels on a chip.  Regarding readout, optical 
path length crossing nanochannels is too short for TLM, and therefore, we added wave 
optics to TLM for detect localized photothermal effect from the target molecules as 
described in the caption of Fig. 2b.  After that, we have devoted ourselves to the extended-
nano fluidic device technology and intensively reported fabrication and detection 
technologies.   
Nano fabrication techniques of the Si semiconductor were modified for the fused silica and 
glass substrates which are just Si oxide and hard enough for nano fabrication and 
structures.  The breakthrough technologies from micro to nano fluidics are,  
bn-1) partial surface modification,  
bn-2) low temperature glass bonding.  
Inside of a nanochannel is quite unique space influenced by surface of the channel wall.  
Therefore, chemical surface control is much more definitive than a microchannel, and 
partial surface modifications at carefully designed local spots, bn-1), are needed.  
Therefore, our low temperature bonding, bn-2), between a cover glass substrate and a 
fabricated and surface functionalized glass substrates is quite important to keep the surface 
chemical functions inside the nanochannels.  There are other techniques for nanofluidics, 
but they are left out for want of a space.   
Fig. 5. Commercialized microfluidics 
based enzyme-linked immunosorbent 
assay (ELISA) system, and its 
schematic illustration of the working 
principle. 
 
   
It is difficult to access to nanochannels 
from our macroscale world, and a 
stepwise fluidic system from macro to 
nano via micro fluidics as shown in Fig. 
6a is indispensable.  This illustration is 
our strategy and platform of 
nanofluidics, and actually we realized 
these technological platforms and 
examples were demonstrated in Figs. 6b 
and 6c.   
4.	  Breakthrough	  given	  by	  
nanofluidics:	  A	  novel	  tool	  for	  
science	  and	  technology	  
The ultimate smallness of nanofluidics 
enables chemistry and biomedical 
science at pico, femto, and even atto liter 
scale.  Number of the target molecules 
becomes countable in this smallness.  
For example, we successfully 
demonstrated atto-liter chromatography 
separation, femto-liter and single-to-
countable molecules immunoassay (Fig. 
6b), and femto-liter solvent extraction.  
These applications are also combinations 
of nano unit operations, which is the 
same as MOU in microfluidics.  
Especially, in case of the immunoassay, the significant signals from single to countable 
antigen proteins were obtained and we proved the principle of single molecule 
immunoassay.   
Unique properties and characteristics 
of liquid and fluid were found.  For 
example, viscosity of water is several 
times larger than normal water, 
dielectric constant becomes 1/7, 
proton conductivity is two hundred 
times larger, fluid at the channel wall 
is slipping and its velocity is not zero, 
and so on as shown in Table 2.  
Water molecules in a glass 
nanochannel strongly interact with 
the channel wall, and the nature of 
molecule as a particle becomes 
remarkable in nano scale condensed 
phase.   
 
 
Fig. 6. (a) Schematic of micro/nano hybrid 
fluidics. (b) Nanochannels connecting to the 
microchannel, which is for single molecule 
immunoassay at 100 femto liter sample. (c) 
Solar light driven self rechargeable m-fuel cell 
device by micro/nano hybrid fluidics.  Left hand 
side is the fuel generator, and the right hand 
side is the fuel cell. 
Table 2. Property changes of water in nanochannels. 
 
   
In this way, nanofluidics is 
surely making progresses.  
We call our nanofluidics as 
"extended-nano fluidics" 
and will continue it, 
because we are interested in 
ultimatum of condensed 
phase and uninterested in 
isolated single molecules at 
single-digit nano space.  
Our intention is going well, 
and researchers having the 
same ambition and 
expectation are now making 
a community and sharing 
common prospects 
described in the next 
section.   
5.	  Prospects	  
It is a matter of time that microfluidics brings breakthrough in many science and 
technology fields.  Actually, the customers of our spin off company, Institute of 
Microchemical Technology (IMT), are now mainly companies and researchers of 
application side, although the main customers were microfluidics researchers ten years ago.  
But it has not made a big market yet.  For the real implementation of microfluidics in 
industry and science, there are still some technologies to be developed.  System 
technology, design method, and online flow control mechanism are the typical issues.  
However, we are feeling anticipation that microfluidics will break into a big market and 
contribute to science, industry, and society.   
Regarding nanofluidics, the technologies at ultimate small volume and unique 
characteristics appearing in there may innovate chemistry from mole to number of 
molecules, and bring breakthrough tools to many kinds of science and technologies like 
biology in and between cells, pathology at cell level, fluid mechanics at molecular picture, 
and so on (Fig. 7).  Actually, the young researchers in these fields are getting together in 
our lab, expecting to get a novel and powerful research tools.   
Microfluidics and nanofluidics are worthy of paying attention to make sure that they will 
innovate science and technology and create new values in industry and society.   
References	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Fig. 7. Nanofluidics in near future. 
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Protein	  self-­‐assembly	  and	  misassembly	  	  
Protein molecules provide the functional basis for biological pathways in living systems. 
While a subset proteins are active as monomeric entities, for instance as enzymes, in the 
majority of cases, proteins are only able to fulfil their key biological roles in nature through 
self-assembly together with other protein molecules into supra-molecular structures that 
form the machinery of life. In cases where proteins bind an incorrect partner, misassembled 
and pathological supra-molecular structures can result.  
A general class of such misassembled protein structure is that of amyloid aggregates. These 
species were initially discovered in the context of pathology where their formation is a 
hallmark of a range neurodegenerative disorders. These materials, including nanoscale 
amyloid fibrils, are characterised by the presence of a densely packed beta sheet rich 
hydrogen bonding network at their core, which confers a high level of chemical and 
mechanical stability and renders the assembly of these structures essentially irreversible 
under normal biological conditions, leading to the disruption of normal cellular pathways 
when their formation occurs in an uncontrolled manner in the context of disease. Moreover, 
lower molecular weight oligomeric amyloid species, formed from precursor peptides and 
proteins which can be entirely innocuous and normally present in the cytoplasm of cells, are 
in general potent toxins, and contribute significantly to the loss of cell viability in the 
context of neurodegnerative disorders.  
Despite these key roles of supra-molecular protein self-assembly in both biological function 
   
 
and malfunction, this process has remained challenging to characterise in a quantitative 
manner. This situation arises partly due to the highly dynamic and heterogeneous nature of 
the species which are formed as a result of protein self-assembly, characteristics which 
render these systems less suited for study using well established tools of structural biology. 
Over the past ten years, we have focused our efforts into developing and applying new 
micro and nanoscale methods leveraging physics and engineering concepts in the context of 
protein science. This talk outline some results in the context of using micron scale flow 
control to probe protein self-assembly in the condensed phase in the natural environment of 
proteins, but at resolutions increasingly approaching state of the art gas phase mobility 
measurements. Moreover, we will discuss recent efforts that we have undertaken to extend 
the space of protein material architectures by bringing together protein self-assembly with 
microfluidic control of fluid flows.  
Probing	  protein	  self-­‐assembly	  on	  small	  scales	  	  
We have focused our efforts on exploring experimental strategies to provide a new window 
into protein self-assembly that are enabled by operation in small volumes and that do not 
have a bulk equivalent. We have shown that microconfinement achieved through droplet 
microfluidics allows the isolation of single nucleation events in protein aggregation and 
thus to study a rare event as single molecule resolution. Using this strategy we have also 
been able to develop an understanding of how aberrant misfolded protein states are 
transmitted from one molecule to another through time and space. More recently we have 
exploited measurements of mass transport through fluid streams under laminar flow 
conditions to generate a platform for probing protein-protein interactions under fully native 
conditions.  
	  
	   	  
Figure 1: Use of confinement to probe protein self-assembly from single nucleation 
events (left and middle - PNAS (2011) 108, 14746) to force generation from self-
assembly (right - Nature Physics (2016) 12, 926). 
 
   
 
Expanding	  the	  materials	  space	  accessible	  using	  protein	  structures	  	  
In nature, high performance materials, including spider silk and the cytoskeleton are formed 
from protein molecules through self-assembly. Capitalising on this natural ability of protein 
molecules to self-assemble to generate new artificial biomaterials from natural building 
blocks has been frustrated by the difficulty in controlling protein self-assembly to generate 
structures and materials outside of those selected by evolution. We have sought to address 
these limitations by bringing together filamentous amyloid protein assembly with micron 
scale control of fluid flows.  
Amyloid fibrils are a common form of protein nanostructure resulting from the aggregation 
of soluble proteins into supramolecular polymers, which possess remarkable physical 
properties, including a high Young's modulus and tensile strength and the ability to self-
assemble under mild conditions in aqueous solution. Such structures were initially 
identified in nature as pathological protein deposits, yet recently have emerged as key 
functional components in biological materials found in organisms ranging from bacteria to 
humans. However, the applications of the general nanofibrillar amyloid scaffold have been 
limited by the challenges in enabling the overall micronscale morphology to progress 
beyond spatially uniform gels. By combining the inherent nanoscale self-assembly process 
with micron scale structuring, afforded by droplet microfluidics, we establish a class of 
physical microgels based on nanofibril-forming proteins that are easy to synthesize, 
biodegradable and nontoxic and that show advantageous characteristics as vehicles for the 
encapsulation and release of active proteins such as antibodies or small molecules, 
including drugs. 
 
Figure 2: Artificial biomaterials from amyloid fibrils. We have approached the challenge of 
synthesising new functional materials from natural building blocks by bringing together protein 
self-assembly with microfluidic techniques to form protein microgels, shells and capsules, 
opening up novel material architectures not found for proteins in nature (Nature 
Communications (2016) 7, 12934, Nature Communications (2016) 7, 13190), Science (2007) 
318, 1900, Science (2009) 326, 1533. 
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Background	  
While next generation sequencing evolves rapidly, and will eventually become cost-
effective enough to meet the bandwidth of genetic analysis needs, electrophoresis with 
multicolor detection still provides the foundational technology for many scientific arenas 
where comprehensive sequence information is not necessarily needed. 
One application is DNA-based human identification (hID), where the length of a collection 
of tetra- and penta-nucleotide short tandem repeats (STRs) from different regions in the 
   
 
genome are unique to an individual; 
at the time of selection, these had 
no clinical relevance.  The sizing of 
short tandem repeat sequences 
(STRs) from 13-24 genetic loci can, 
collectively, provide discriminatory 
power that allows the random match 
probability (RMP) that two 
individual have exactly the same 
STR profile to be on the order of 
one in trillions (Fig. 1).   
‘Rapid’	  DNA	  systems	  	  
In  2008, the federal government 
funded the development of ‘Rapid 
DNA’ systems – genetic analysis 
systems that could provide sample-
to-genetic profile in an automated format and in less than 90 min [J Forensic Sci. 
58(4):866-74, 2013].  Several university start-ups were involved in developing 
commercializable systems specifically for generating STR profiles from buccal swabs, with 
the ultimate goal being to employ these systems in booking stations (with or without 
association with a forensic lab) throughout the USA .  The nationwide DNA typing of 
convicted felons has been in effect for some time, but now ‘Katie’s Law, the routine 
collection of buccal swabs upon arrest, is in effect in more than half the states.  
The ‘Rapid DNA’ movement blazed a new trail, an application-driven need that led to the 
integration of sample preparation (DNA extraction) and DNA amplification (PCR) steps 
with electrophoretic separation in a single microfluidic device – a bona fide lab-on-a-chip – 
for automated DNA processing (Fig. 2).  It guided the criminal justice community into a 
new mindset, and forced the federal government to anticipate the policy changes that would 
be needed to allow booking stations to upload the generated STR profiles to the national 
database. However, to-date only a handful of booking stations have adopted the 
technology, and for substantive reasons.  The capital investment is sizable at $250,000-
$280,000 USD, exacerbated by a microdevice cost that, at $150-$500 per sample, makes 
 
Figure 1.  A typical 18-locus profile used as court-
defensible data with a RMP of one in 18 trillion. 
 
Figure 2.  ‘Rapid DNA’ system from one start-up company. (A) The IntrepID from MicroLab-
ZyGEM (Lab Chip  14:4415–4425, 2014.) and (B) the MicroLab-ZyGEM chip capable of 
running 4 samples with swab-to-profile in 60 min.  This chip has a completely self-contained 
fluidic architecture, can accommodate simultaneous analysis of 4 samples, involves a 5-layer 
assembly, has 2 independent fluidic layers accessible through a ‘via’ layer. 
 
   
 
‘Rapid testing’ almost an order of magnitude more costly than standard forensic lab 
analysis.  Moreover, the size of the microdevice and/or the instrument size/weight has 
limited adoption of the ‘Rapid DNA’ technology by other sectors where lightweight, 
portable and cost-effectiveness were important factors.   
The	  faSTR	  DNA	  system	  
The faSTR disc is a 10-layer hybrid system composed of 7 different materials (COC, PE, 
PMMA, PSA, HSA, toner, gold leaf) with 24 chambers and 55 channels on 7 fluidic layers, 
with the fluid flow between layers and throughout the entire fluidic architecture driven by 
centrifugal force and governed by 13 physical valves needed to maintain fluidic isolation of 
the diverse chemistries associated with DNA extraction, PCR and electrophoresis (Fig 3-A 
& B).   
The valves are opened by simple 2-sec irradiation with a 638 nm laser pointer (Fig 3Ci) 
controlled by the software and, guided by optical switch-controlled rotation with 0.1 degree 
accuracy and a radial accuracy of 20µm, hence, able to hit any 100 µm2 area on the chip.  
All reagents are on-chip in lyophilized or blister pack form, including the polymer used for 
electrophoresis with 4-color fluorescence detection. Fluidic control is governed by 
software-controlled rotation speed/direction and the opening of valves. DNA extraction 
from cells collected on a custom ‘break-away’ swab is accomplished by mobilizing a 
thermophilic protease from the blister pack into the buccal swab chamber to generate PCR-
ready DNA.   
The sample DNA is mixed with on-board PCR reagents and thermocycling facilitated by 
‘dual clamp-Peltier’.  The target sequences for amplification include unique short tandem 
repeat (STR) chemistry for a gender marker (amelogenin) and 9 other loci defined as ‘core’ 
by the FBI.  Following rapid PCR, the products are heat-snap cooled to assure the DNA 
denaturation single stranded form for electrophoresis. A novel non-crosslinked sieving 
polymer is mobilized from the blister pack into the electrophoretic domain using 
centrifugal force where, following sample injection, peerless resolution of DNA (2-base) in 
a short separation channel (5 cm) under modest electric fields (2KV) is completed in 300 
seconds with fragment sizes out to 300 bases.  
The instrument brings together a cadre of components required for disc spinning, heating, 
cooling, valving laser translation, clamping, optical detection and optics translation, along 
with the necessary custom-built software that controls all functions including post-
electrophoresis deconvolution of the raw data to generate an ‘STR Profile’ (Fig 3D).  
Heating/cooling is accomplished with the dual Peltier system that facilitates extraction and 
PCR with temperature ramping at 10°C/second, while the detection optics interfaced with a 
blue diode laser that has an auto-alignment function, do not require a fluorescent-agent-
filled channel. This last capability is unique because, unlike standard chip optics that are 
‘hard-mounted’, a microdevice that is free-spinning must be optically aligned prior to 
electrophoresis to assure that detection is at the dead-center point of the 80µmx80µm 
electrophoresis channel. The entire system runs off of AC or battery, with the 
electrophoresis domain powered by a novel ‘step-up voltage’ system custom-built to 
generate 2000V from two 9V batteries.   
   
 
In a sample in-answer out data generated from a buccal swab in 60 min compares favorably 
with the data from conventional analysis (Fig 3D).  The software guides the instrument 
through DNA extraction, PCR, electrophoresis and detection in an automated 27-step 
protocol with complete hands-off analysis and data generation in 60 min.  This data is 
suitable for forensic human ID, but the application bandwidth is obvious, extrapolable to 
other points of analysis (POA).  These include on-site analysis at mass disaster sites and for 
immigration control.   
In summary, we have developed a portable genetic analysis system that is unprecedented in 
its capability, speed, size and weight, and eventually, cost.  It breaks through the ‘adoption 
barriers’ set by ‘Rapid DNA’ technology and, perhaps, more important than all of the other 
parameters, is poised to bring a paradigm-shift to genetic analysis, as a result of its cost-
effectiveness.   
 
 
 
Figure 3. (A) The faSTR microfluidic disc highlighting the gold leaf electrodes and blister packs. 
(B) Assembly of the integrated disc with the individual features needed with functionality.  (C) 
Laser valving using an inexpensive red laser pointer and the custom swabs for sample 
insertion. (D) The faSTR instrument and comparison of a 10-locus STR profile generated by 
conventional methods (left) and the fully-integrated faSTR system (right). 
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Abstract	  
One of the earliest successful innovations in advanced microfluidics relates to the 
development of the optical biosensor instrument Biacore. The company Pharmacia 
Biosensor AB (later renamed to Biacore AB and then acquired by GE Healthcare in 2006) 
in Sweden started research and technology development in 1985 and, thanks to major 
breakthroughs in surface chemistry, detector development and microfluidics based sample 
handling, could successfully launch the first in a long series of bioanalytical platforms in 
1990. 
The implementation of label-free, real-time interaction analysis based on the optical surface 
plasmon resonance (SPR) detection technology into a functional, user-friendly and 
quantitative analytical system was made possible by these technological developments. The 
SPR based Biacore systems has proven to be a versatile, general tool for studies of the 
affinity and kinetics of protein and biomolecular interactions within academic life science 
research, drug discovery and development, manufacturing and QC. 
Such a technology intended to be used for quantitative interaction studies also put special 
demands on the precision and reproducibility of sample delivery in a miniaturized format to 
the sensor areas in the SPR detector. In addition, multiplexed detection by the utilization of 
several sensor areas will increase the information content and throughput, but have also to 
be matched to the needs for flexible addressing of the samples, in parallel or in sequence.  
   
 
All these requirements emerged into the development of a novel type of miniaturized and 
integrated fluidics unit, controlled by pumps for liquid delivery over the sensor surface and 
with an autosampler handling module within the Biacore instrument for transfer from vials 
or microtitre plates (1).  
The fluidics unit (or cartridge) is composed of micro-channels integrated with diaphragm 
valves that are pneumatically operated to facilitate rapid switching between buffer flow and 
delivery of samples as well-defined sample plugs (Figure 1). The valves are located close 
to the sensor areas, thereby reducing dispersion to a minimum. The flow channels are 
formed by precision casting in a hard silicon polymer plate. The thin-layer flow cells are 
formed by pressing the sensor chip against an area of the cartridge with multiple open 
rectangular grooves at the outlet side of the micro-channels. Typical dimensions for the 
flow cell are 1.6 mm long, 500 µm wide and 50 µm high, with a total detection cell volume 
of 40 nanolitres. The thin-layer flow cell enables optimal mass transfer conditions with 
linear flow rates from 1 to100 µl/min and under laminar flow conditions.  
The fluidics cartridge is typically in operation in the instruments over a period of 6 months 
with up to 24/7 usage. The pneumatic valves can open and close hundreds of thousand 
times during that period at an air pressure of 250 kPa without any significant deterioration 
in performance. The material withstands all commonly used buffers and regeneration 
solutions for bioanalytical applications, including extreme pH conditions from pH 1 to 13.      
Later versions of the fluidic cartridge have been developed for use in higher throughput 
versions of Biacore instruments. For example, a cartridge configured with a fluidic system 
with 4 parallel flow cells, each including five detection spots enables individual addressing 
of each spot by using hydrodynamic flow steering (Figure 2). This can be used for precise 
in situ immobilization of multiple ligands within different areas in the flow cell. This 
configuration also enables flexible assay configurations and facilitate generation of several 
hundred and up to thousands of data points in automated runs.  
 Valves 
Sensor chip  
Valve 
Figure 1. Biacore microfluidic cartridge 
   
 
There is no doubt that the main reason for the wide acceptance of the Biacore’s technology 
has been driven by its use in quantitative kinetics and affinity analysis of biomolecular 
interactions within basic and applied research. This is evident from the steady stream of 
peer reviewed papers published since 1990 and with several thousand instruments on the 
market. Up to 2016 more than 15 000 papers based on data obtained on Biacore 
instruments can be tracked. It is evident that the implementation of the high quality 
integrated microfluidics has played a crucial role in the acceptance and commercial success 
of Biacore. This presentation will describe the historical aspects of this development as 
well as more recent advances of Biacore microfluidics and use in various applications. 
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4 flow cells - 5 monitored spots 
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Figure 2. Microfluidic cartridge for Biacore 4000 
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Summary	  of	  the	  talk	  
Microfluidics is a field of measurement science. Many successful microfluidic systems that 
have been developed in the last couple of decades have aimed at increasing throughput for 
measurements and enhance the precision of the measurements that are being made.  In 
parallel, other microfluidic systems provide unique measurement opportunities and bring 
about new information otherwise unavailable through conventional assays. Development of 
new tools continue to change the way the measurements are made and used, to study a 
variety of biological questions.  In this talk, I will focus on a few sets of tools my lab has 
developed in the context of organismal development, cellular function, and neural basis of 
behavior in small animals; I will also highlight the power of combining microfluidics with 
data science and automation.   
   
	  
Cell	  trap	  arrays	  and	  other	  microfluidic	  devices	  for	  cell-­‐based	  assays	  
Stimulating and imaging large number of cells over time, especially non-adherent cells are 
challenging.  The Lu lab developed a cell trap array, which enables deterministic single-cell 
trapping and dynamic imaging of thousands of cells simultaneously while controlling their 
biochemical/physical microenvironment (Chung, Rivet et al. Analytical Chemistry 2011).  
This chip allows for thousands of cells to be imaged simultaneously, at single-cell 
resolution, while allowing for easy infusions of drugs or stimuli over the cells since 
microfluidics allows for simple integrations of complex upstream functionalities. Further 
variations of this device have also been developed (Chingozha et al. Analytical Chemistry 
2014; He Kniss et al., Lab Chip, 2015; unpublished data), to allow complex stimulation 
patterns while performing live imaging, as well as end-point assays such as protein 
immunohistochemistry and in situ mRNA quantification, all at single-cell resolution. These 
techniques allow researchers to expand the type of phenotypical analyses that can be done 
on a single-cell level, for many cells, and correlate the phenotypes.  We envision these 
systems to be of particular interest for cell biologists to study immunology, stem cell 
biology, and developmental biology. 
Microfluidics	  for	  studying	  embryos	  and	  development	  in	  vitro	  
Related to the cell traps, we have also developed a series of devices for larger samples such 
as Drosophila embryos and stem cell aggregates.  The fruit fly Drosophila melanogaster is 
a model organism for embryo development and tissue morphogenesis. Typical studies of 
the dorsal-ventral patterning process require painful manual mounting and alignment of 
fragile embryos.  The throughput of these experiments traditionally has been a few 
embryos per many months.  The Lu lab has developed a microfluidic device for arraying, 
orienting, and high-resolution imaging of hundreds of Drosophila embryos (Chung, Kim et 
al. Nat. Meth. 2011), whose throughput is at least 100x faster than manual methods. This 
technology takes advantages of several hydrodynamic effects, together allowing an 
extremely high efficiency and success rate while avoiding complex instrumentation off-
chip.  Because of its facile utility, the chip has been used in many subsequent publications 
in collaboration with Shvartsman lab (Princeton U.) dealing with signal transduction in the 
ventral-dorsal patterning process (e.g. Kim et al. Developmental Cell 2011; Kanodia et al. 
Development 2011; Kanodia et al. Biophys J. 2012; Helman et al. Development 2012, 
Kanodia et al, Biophysical J. 2012; Lim et al PNAS 2013; Dsilva et al Development 2015; 
Samee et al Cell Systems 2015). Further development of this type of systems resulted in 
arrays to image embryos in different orientation and longer-term live imaging, as well as 
applications in cancer biology using Drosophila models (Levario et al Scientific Reports 
2016; Goyal Levario et al, Disease Models & Mech 2017) 
Microfluidic	  systems	  for	  high-­‐throughput	  screens	  and	  image-­‐based	  
genetics	  and	  genomics	  	  	  
The Lu lab works on micro technologies to revolutionize microscopy, phenotyping, and 
visual screens of multicellular organisms such as the nematode C. elegans. Imaging is 
extremely powerful in understanding how complex processes are orchestrated in vivo.  
Currently standard technologies widely used in biology laboratories and drug discovery 
processes suffer the drawbacks of being low-throughput, manual, and non-quantitative. The 
   
	  
Lu lab designed a series of microfluidic devices image markers (e.g. fluorescent 
transcriptional markers or fusion proteins) for genetic screens, where the integrated system 
takes in a mutagenized population and is designed to have mutants sorted based on altered 
morphometric phenotypes. The lab has developed several strategies to immobilize worms, 
including cooling (for imaging marker that do not change rapidly, Chung et al, Nat. Meth. 
2008), geometrical constraint (for non-stringent immobilization criterion, Crane et al. Lab 
Chip 2009, Caceres et al, PLoS ONE 2012), and using a biocomplatible gel that transitions 
from solution to gel phase upon 2 °C temperature change (for imaging at physiological 
conditions, e.g. imaging synaptic vesicle trafficking and calcium dynamics, Krajniak et al. 
Lab Chip 2010).  These devices streamline the handling and examination of C. elegans, and 
allows for morphometric screens to be performed much more easily than manual methods. 
Furthermore, the Lu lab has also focused on automation, image processing, and 
classification, which are integrated with the microfluidic chips to achieve the high-
throughput experimentation.  These techniques address one of the significant drawbacks of 
manual screening approach, which is the fact that phenotypes are identified subjectively by 
a user.  This approach is sufficient in experiments where phenotypical changes are dramatic.  
However, most experiments using fluorescent markers now look for subtle changes, such 
as slight changes in intensity, location, distribution, size, and shape.  By using computer 
vision, quantifications of these features on the fly are now possible and the classification of 
the sample much more accurate. For example, the Lu lab developed a set of machine vision 
techniques to identify synapses from background fluorescence, and use this information to 
find new mutants with altered synaptic marker localization (Crane et al. Nat. Meth., 2012). 
More recently, the Lu lab has developed yet another set of data-driven computational tools 
to understand genotypical-phenotypical relationships (San Miguel, Nat. Comm. 2016). 
Phenotypical heterogeneity in isogenic populations greatly reduces our ability to detect 
subtle mutants; however, by exploiting the power of the high-throughput microfluidic 
systems and statistical approaches, we show that we can resolve extremely subtle and 
complex differences between genotypes.  Further, deep phenotyping using these complex 
traits allow us to gain an understanding of how genetic networks influence phenotypical 
manifestation.  
Microfluidics-­‐based	  behavioral	  and	  neural	  imaging	  assays	  to	  study	  
sensory	  neurobiology	  
Another area that the Lu lab is interested in is quantitative studies of neural or genetic basis 
of behavior. The technical challenge with behavioral studies is that most assays are 
qualitative. For instance, despite the heroic efforts in chemical identifications of various 
pheromone molecules, not much is known about how these molecules are sensed and how 
chemical communication is achieved using a combination of these small molecules. 
Behavior assays typically performed with these compounds usually require large amounts 
of chemicals and manual manipulations and tracking of animals.  The Lu lab developed a 
microfluidic device to house many C. elegans in parallel but individually (Chung, Zhan et 
al. Lab Chip 2011).  Chemicals can be delivered with temporal accuracy and behavior can 
be tracked and analyzed by image processing code automatically. The device uses only a 
fraction (~1/100) of the chemicals required to perform these assays and can be potentially 
used for long-term culture and assay of behaviors in worms.   
   
	  
Recently, the Lu lab has developed a microfluidic platform for delivering robust and 
precise mechanical stimuli to C. elegans by using pneumatically actuated structures (Cho 
Porto et al Lab Chip 2017; unpublished data). The device is fully automated, minimizing 
human variability and improving experimental throughput; it is fully compatible with 
fluorescent imaging of calcium dynamics of neurons. We show that this device can deliver 
mechanical stimuli with precise control in timing, location, and deformation.  These 
characteristics allow us not only to recapitulate the well-known receptive field of the 
neurons in the gentle-touch circuit, but also to understand the dynamics of the harsh-touch 
neurons.  We further developed this microfluidic system to interrogate behavior of 
mechanosensory neurons during development (both in active larvae and in larvae in 
lethargus state). In a collaborative effort, we are examining how small molecules may 
affect the signal transduction properties of human Transmembrane channel-like proteins in 
heterologous systems. Our microfluidic system directly addresses the current bottleneck of 
a lack of functional assay for such drug screens. The ability to automate and streamline the 
microfluidic system will greatly enhance our ability to identify potential therapeutics.  
In summary, we show that microfluidics is instrumental in gathering biological information 
difficult or impossible to do with conventional techniques, and in studying genes and 
pathways in fundamental biological processes, which may be potential targets for future 
therapeutic development. We believe good designs are grounded in understanding of the 
fundamentals.  Robustness and demonstrations of success are key to useful technologies for 
scientific discoveries. The future may lie in integration with other aspects of measurement 
sciences, such as quantitative analysis, particularly using statistical approaches.   
This work is supported by funding from the US National Institutes of Health, the US 
National Science Foundation, and the Love Family Foundation. 
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Abstract	  
The idea to shrink a laboratory down to chip size, or at least to integrate some critical 
chemistry lab tasks onto micro devices has been around since almost 30 years now. A 10x 
smaller scale means 100x faster throughput for chemical reactions or separations, if 
diffusion controlled. In the meantime, the field has grown significantly, many of my 
students are now professors in this field, the early patents are all expired, small companies 
use microfluidics for their products, and the main application focus has shifted from 
analytical chemistry to cell biology and tissue engineering. But where are the throughput 
benefits for chemical reactions or bioassays? [1]  
I intend to show a personal perspective of all this, as I was involved since the early days. 
The case of electrophoresis on chip, from scaling laws to applications and 
commercialization will be shown. Drug discovery, combinatorial synthesis or clinical 
diagnostics could be applications, but just a fraction of it is actually in use. 
Currently, the playground appears to have moved to different fields of interest. From my 
lab, I might show developments of remote controlling individual magnetotactic bacteria, of 
scaling self assembly concepts and of biomimetic structures obtained from nature. 
Microfluidic chips are usually defined by photolithography masks which are generated 
from straight lines and CAD programs. The manufacturing process needs clean room 
technology and usually gets more complex if multiple depths, i.e. multiple masks have to 
be used, and variations in depth profile are difficult to achieve. I will present a simple way 
of obtaining channel structures which feature gradually increasing or decreasing channel 
depths, and which also can feature irregularities in its surface. At first sight, this may seem 
inappropriate, may look “ugly” and not engineering-like. However, in biological 
surroundings, we can see such structures, and they are fully functional. 
Plant leaves are used as templates for channel patterns, including its fine structure and 
including its macroscopic network pattern. Structures are formed in PDMS and covered by 
glass slides for microscopic observation [2]. Structures are used for investigating cell 
behaviour, digital PCR and perfusion of 3d cell cultures.  
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Abstract	  
Brain diseases are among the most serious health problems facing our society, causing 
massive human suffering and economic costs. The lack of understanding the underlying 
disease mechanisms is a major obstacle to the development of better treatments. 
Pathological perturbations of the brain often involve the altered environments and the 
extraordinary complex, yet highly disorganized neural architecture in human brain. As 
such, establishing in vitro brain disease models is critically important to improve our 
understanding of the central nervous system, diseases pathology, potential neurotoxic 
effects of environmental factors, and the development of effective treatment. In this talk, I 
will present our efforts to establish several near-physiological brain disease models using 
microfluidic approaches combining with classical cell biology strategy. I will also 
demonstrate the utilities of microfluidic platforms for applications in probing the cellular 
pathology and mechanisms underlying brain tumor metastasis, and brain developmental 
disorders after various chemicals exposures. 
1.	  Engineering	  the	  in	  vitro	  blood-­‐brain-­‐barrier	  microenvironment	  to	  
probe	  brain	  metastasis	  	  	  
Evidence suggests that the physical, cellular, and non-cellular microenvironment of defined 
anatomical regions within the brain may contribute to the aggressiveness and resistance to 
the treatment of brain tumors. The blood brain barrier (BBB) is a dynamic interface 
between the blood and brain in vivo. The dysfunction of this barrier is closely associated 
with the brain tumor. The BBB restricts the uptake of many neuro-therapeutic molecules, 
presenting a formidable hurdle to elucidate the mechanism and drug development in brain 
diseases. We proposed a new and 3D dynamic microfluidic system that replicates the key 
structural, functional and mechanical properties of the BBB in vivo (Fig 1). Multiple 
factors in this system work synergistically to accentuate BBB-specific attributes-permitting 
   
 
the analysis of complex organ-level responses in both normal and pathological 
microenvironment in brain tumors. The complex BBB microenvironment is recreated in 
this system via physical cell-cell interaction, vascular mechanical cues and cell migration. 
This model possesses the unique capability to examine brain metastasis of human lung, 
breast and melanoma cells and their therapeutic responses to chemotherapy. The results 
suggest that the interactions between cancer cells and astrocytes in BBB microenvironment 
might affect the ability of malignant brain tumors to traverse between brain and vascular 
compartments, providing a versatile platform for drug testing and brain disease studies.    
2.	  Engineering	  stem	  cell-­‐based	  brain	  organoids	  to	  study	  brain	  
developmental	  disorders	  
 The human brain is susceptible to many different disorders that appear at every stage of 
life. The fetal brain is highly vulnerable to various environmental exposures, which can 
trigger various long-term neuronal disabilities and cognitive dysfunctions. However, a 
comprehensive understanding of fetal brain development under toxic exposures is 
challenging due to the limitations of animal models. As such, we proposed a novel 
microfluidic strategy by combining with development biology to explore the mechanisms 
underlying neural dysfunctions with various environmental exposures, such as ethanol and 
nicotine. The functional microfluidic device enables the generation of human induced 
pluripotent stem cells (hiPSCs)-derived brain organoids in a simple and efficient manner 
(Fig 2). The 3D brain organoids recapitulate human brain organogenesis at early stages 
during gestation, including neuronal differentiation, brain regionalization, and cortical 
organization. With exposures, the brain organoids displayed skewed neurogenesis and 
persistent abnormity in neural maturation. A series of markedly altered genes and enriched 
  Fig 1. BBB-on-a-chip 
   
 
pathways related to neurogenesis, craniofacial development and brain volume contribute to 
our understanding of the various postnatal neural disorders as observed in brain 
development disorders.  
Overall, our work described the creation of in vitro brain disease models by incorporating 
the key essentials of brain microenvironment and brain organogenesis into the microfluidic 
devices. These work meld the concepts and engineered techniques with classic cell biology 
and developmental biology strategies to exploit the pathophysiology of brain diseases. The 
microfluidic technology is expected to provide a powerful tool to investigate cellular and 
molecular mechanisms underlying various brain disorders and to guide effective treatment.   
 
 
Fig2. Brain organogenesis-on-a-chip  
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Abstract	  
This talk will provide a brief overview of drop-based microfluidics, with a discussion of the 
fundamentals of drop formation, and the use of the technology for both production of new 
materials and for ‘lab-on-a-chip’ applications.   
The first use of drop-based microfluidics that I will describe is for production of new 
materials.  Microfluidic devices enable precise control of the flow and mixing of fluids to 
produce drops of one fluid in a second, creating an emulsion.  They can also produce drops 
within drops to create more complex, multiple-emulsion structures.  This talk will review 
capillary microfluidics, a very simple means of creating microfluidic devices that can 
produce multiple emulsions.  Exquisitely precise new structures can be created that possess 
both new properties and new utility.  The talk will describe the production and properties of 
such multiple emulsion drops.  In addition, the talk will describe methods to up-scale the 
production of these materials for practical materials applications.   
The second use of drop-based microfluidics that I will describe is the ‘lab-on-a-chip’ 
applications for biology and biotechnology.  Aqueous drops whose volume is between 
about one picoliter and about a nanoliter can be produced in an inert carrier oil, and can 
serve as reaction vessels for biological assays. These drops can be manipulated with very 
high precision, with the carrier oil controlling the fluidics, ensuring the samples never 
contact the walls of the microfluidic channels.  Small quantities of other reagents can be 
injected with a high degree of control.  The drops can also encapsulate cells, enabling cell-
based assays to be carried out.  Hydrogel particles can be co-encapsulated within the drops 
   
 
to add genomic barcodes to the cell material, and thereby enable very high throughput 
sequencing with single-cell resolution.  The use of these devices for studies of biology and 
for biotechnology applications will be described.   
Both of these applications of drop-based microfluidics lead to new and interesting science, 
and to myriad applications, both in the production of new materials, and in biotechnology 
applications to improve human health. 
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Abstract	  
Centrifugal microfluidics enables efficient miniaturization, integration, parallelization and 
automation of biochemical assays especially for Point-of-Care applications. This talk will 
demonstrate fully integrated sample-to-answer genotyping assays from whole blood which 
enables rapid and multiplexed molecular diagnostics of infectious diseases. The assays are 
implemented on a LabDisk which is fabricated by micro-thermoforming from thin polymer 
films and are performed within 3 hours on a small and lightweight instrument.  
Additionally advanced centrifugal unit operations will be presented such as centrifugal step 
emulsification merging droplet microfluidics with centrifugal microfluidics. This unit 
operation enables centrifugal droplet generation, DNA amplification and fluorescence 
detection within one single cavity of a disposable chip. It enables significant 
miniaturization of future devices for digital assays as well as acceleration of fully 
automated point of care testing within less than 1 hour. Results for absolute quantification 
of DNA by digital droplet-RPA,-LAMP and -PCR amplification using the novel unit 
operation are in good agreement with those obtained by a commercial state-of-the-art 
dPCR system. Finally, challenges and solutions for the scale-up of manufacturing the 
polymer LabDisk by microthermoforming will be discussed. 
